230 related articles for article (PubMed ID: 21375435)
1. Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.
Thomas R; Seiser EL; Motsinger-Reif A; Borst L; Valli VE; Kelley K; Suter SE; Argyle D; Burgess K; Bell J; Lindblad-Toh K; Modiano JF; Breen M
Leuk Lymphoma; 2011 Jul; 52(7):1321-35. PubMed ID: 21375435
[TBL] [Abstract][Full Text] [Related]
2. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma.
Thomas R; Borst L; Rotroff D; Motsinger-Reif A; Lindblad-Toh K; Modiano JF; Breen M
Chromosome Res; 2014 Sep; 22(3):305-19. PubMed ID: 24599718
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.
Hedan B; Thomas R; Motsinger-Reif A; Abadie J; Andre C; Cullen J; Breen M
BMC Cancer; 2011 May; 11():201. PubMed ID: 21615919
[TBL] [Abstract][Full Text] [Related]
4. 'Putting our heads together': insights into genomic conservation between human and canine intracranial tumors.
Thomas R; Duke SE; Wang HJ; Breen TE; Higgins RJ; Linder KE; Ellis P; Langford CF; Dickinson PJ; Olby NJ; Breen M
J Neurooncol; 2009 Sep; 94(3):333-49. PubMed ID: 19333554
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.
Roode SC; Rotroff D; Avery AC; Suter SE; Bienzle D; Schiffman JD; Motsinger-Reif A; Breen M
Chromosome Res; 2015 Dec; 23(4):681-708. PubMed ID: 26037708
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
Fosmire SP; Thomas R; Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Smith TL; Gardner LA; Ritt MG; Bell JS; Freeman KP; Greenfield BE; Lana SE; Kisseberth WC; Helfand SC; Cutter GR; Breen M; Modiano JF
Vet Pathol; 2007 Jul; 44(4):467-78. PubMed ID: 17606508
[TBL] [Abstract][Full Text] [Related]
7. Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
Aricò A; Ferraresso S; Bresolin S; Marconato L; Comazzi S; Te Kronnie G; Aresu L
PLoS One; 2014; 9(11):e111817. PubMed ID: 25372838
[TBL] [Abstract][Full Text] [Related]
8. Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs.
Castagnola P; Zoppoli G; Gandolfo S; Monticone M; Malacarne D; Cirmena G; Brown D; Aiello C; Maffei M; Marino R; Giaretti W; Pentenero M
PLoS One; 2015; 10(11):e0142294. PubMed ID: 26540282
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel genomic aberrations in AML-M5 in a level of array CGH.
Zhang R; Lee JY; Wang X; Xu W; Hu X; Lu X; Niu Y; Tang R; Li S; Li Y
PLoS One; 2014; 9(4):e87637. PubMed ID: 24727659
[TBL] [Abstract][Full Text] [Related]
10. [Cytogenetic analysis in the definition and classification of non-Hodgkin's lymphomas].
Polito P; Perin T; Cilia A; Carbone A
Pathologica; 1994 Aug; 86(4):337-49. PubMed ID: 7708433
[TBL] [Abstract][Full Text] [Related]
11. Canine urothelial carcinoma: genomically aberrant and comparatively relevant.
Shapiro SG; Raghunath S; Williams C; Motsinger-Reif AA; Cullen JM; Liu T; Albertson D; Ruvolo M; Bergstrom Lucas A; Jin J; Knapp DW; Schiffman JD; Breen M
Chromosome Res; 2015 Jun; 23(2):311-31. PubMed ID: 25783786
[TBL] [Abstract][Full Text] [Related]
12. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence.
Jones RA; Moorehead RA
Genes Chromosomes Cancer; 2019 Jun; 58(6):381-391. PubMed ID: 30597648
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of canine mast cell tumors identifies DNA copy number aberrations associated with KIT mutations and high histological grade.
Mochizuki H; Thomas R; Moroff S; Breen M
Chromosome Res; 2017 Jun; 25(2):129-143. PubMed ID: 28058543
[TBL] [Abstract][Full Text] [Related]
16. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
17. Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.
Dai H; Ehrentraut S; Nagel S; Eberth S; Pommerenke C; Dirks WG; Geffers R; Kalavalapalli S; Kaufmann M; Meyer C; Faehnrich S; Chen S; Drexler HG; MacLeod RA
PLoS One; 2015; 10(11):e0139663. PubMed ID: 26599546
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma.
Bryan JN; Jabbes M; Berent LM; Arthur GL; Taylor KH; Rissetto KC; Henry CJ; Rahmatpanah F; Rankin WV; Villamil JA; Lewis MR; Caldwell CW
BMC Genet; 2009 Nov; 10():73. PubMed ID: 19912643
[TBL] [Abstract][Full Text] [Related]
19. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
[TBL] [Abstract][Full Text] [Related]
20. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
